Prostate cancer decisions — 2025

The Board denied the veteran's request for a rating higher than 40% for prostate cancer. The evidence did not show that the veteran's symptoms required changing absorbent materials more than four times a day.

The Board denied the Veteran's request for an earlier effective date prior to October 22, 2021, for service connection of prostate cancer.

The appeal regarding the reduction of the prostate cancer rating was dismissed. The claim for service connection for an eye disability, including glaucoma, was reopened but ultimately denied. Claims for service connection for shakes/tremors and soft tissue sarcomas were also denied.

The Board remanded the veteran's claims for service connection of diabetes mellitus, prostate cancer, and hypertension. The veteran will receive a VA examination to determine if these conditions are related to his military service.

The veteran's appeal for a permanent and total rating for service-connected prostate cancer was granted. The condition is considered permanently incapacitating.

The Veteran's appeal for service connection of prostate cancer was granted. The Board found that the Veteran's prostate cancer is due, at least in part, to exposure to fuel during his military service.

The Board denied service connection for diabetes mellitus, type II, prostate cancer, erectile dysfunction, and diabetic peripheral neuropathy in all extremities due to lack of evidence linking these conditions to the veteran's service.

The veteran's appeal for a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities was granted. The decision is based on the veteran's significant functional impairment and inability to maintain a substantially gainful occupation.

The appeal for service connection of prostate cancer was dismissed because the veteran withdrew it to pursue a supplemental claim.

The veteran's service-connected PTSD and prostate cancer residuals prevent him from obtaining or maintaining gainful employment, so he is granted total disability on individual unemployability (TDIU) effective December 30, 2022.

The Board granted an earlier effective date of January 1, 2009 for the veteran's Dependency and Indemnity Compensation (DIC) benefits. The decision was based on the veteran's presumed exposure to herbicide agents during service in Vietnam and the subsequent inclusion of bladder cancer as a presumptive disease.

The appeal for service connection of prostate cancer is remanded to correct errors in the duty to assist and to obtain a proper medical opinion.

The veteran's service-connected PTSD and prostate cancer residuals prevent him from obtaining or maintaining gainful employment, so he is granted total disability on individual unemployability (TDIU) effective December 30, 2022.

The veteran's request for a higher rating for ACD was denied, but they were granted TDIU and DEA benefits.

Service connection for both tonsil cancer and prostate cancer has been granted based on the Veteran's in-service asbestos exposure.

Service connection for prostate cancer is granted under the PACT Act. The issue of service connection on a basis other than the PACT Act is remanded.

The appeal for service connection of prostate cancer is remanded. The VA will obtain necessary medical records and conduct an examination to determine if the cancer is related to service.

The Veteran's claims for service connection for erectile dysfunction, headaches, and sleep apnea have been raised by the record.,The Board has remanded these issues to allow for further development.

The Veteran's claims for service connection for prostate cancer, left adrenal gland cancer, and a higher rating for right kidney cancer have been sent back to the VA for further review.

The Board remanded the veteran's claims for service connection for atrial fibrillation, prostate cancer, and COPD due to inadequate medical nexus opinions. The veteran will receive a new decision after additional evidence is obtained.